AbbVie Inc.·4

Mar 3, 6:10 PM ET

Siatis Perry C 4

Research Summary

AI-generated summary

Updated

AbbVie (ABBV) EVP/GC Perry C. Siatis Sells Shares

What Happened
Perry C. Siatis, Executive Vice President, General Counsel and Secretary of AbbVie, disposed of a total of 33,518 AbbVie shares in connection with an option-related tax/withholding transaction and subsequent open-market sales. On 2026-02-27 Siatis surrendered 14,850 shares to cover exercise price or tax liability (reported as code F) at a weighted average of $232.08 for ~$3.45M. On 2026-03-02 Siatis sold 18,668 shares across multiple open-market transactions at weighted average prices of $233.51, $234.66 and $235.26, generating proceeds of about $4.38M. Combined proceeds/consideration across these dispositions are roughly $7.82M. These are sales/withholdings (not purchases) and thus do not represent a new purchase signal.

Key Details

  • Transaction dates: 2026-02-27 (tax/withholding surrender) and 2026-03-02 (open-market sales). Filing date: 2026-03-03 (appears timely under the two-business-day rule).
  • Share counts and reported values:
    • 14,850 shares surrendered (code F) @ $232.08 (weighted avg) = $3,446,388
    • 5,777 shares sold @ $233.51 (weighted avg) = $1,348,987
    • 10,291 shares sold @ $234.66 (weighted avg) = $2,414,886
    • 2,600 shares sold @ $235.26 (weighted avg) = $611,676
    • Total disposed: 33,518 shares for ~$7,821,937
  • Shares owned after transaction: not specified in the excerpt of the filing.
  • Notable footnotes:
    • F1–F3 indicate the reported prices are weighted averages from multiple sale prices within the listed ranges (233.00–233.99; 234.14–235.12; 235.14–235.36). The filer will provide specifics on request.
    • Code F denotes shares surrendered to cover exercise price or tax liability (i.e., withholding), not a cash purchase.
  • Timeliness: Filing date (2026-03-03) follows the transactions on 02-27 and 03-02 and appears to meet the standard Form 4 filing window (filed within two business days).

Context

  • The sequence (shares surrendered for tax/withholding, then additional open-market sales) is consistent with exercising equity awards followed by withholding and sales to cover taxes or take proceeds. The filing shows dispositions, which are routine for option exercises and tax-withholding; they are not the same signal as an insider purchase.
  • No 10% owner or gift/award indicators are present in this excerpt.